This report studies the Cyanocobalamin market, Cyanocobalamin is a man-made form of vitamin B12. Vitamin B12 is important for growth, cell reproduction, blood formation, and protein and tissue synthesis.
Cyanocobalamin is used to treat vitamin B12 deficiency in people with pernicious anemia and other conditions.
The classification of Drugs for Cyanocobalamin includes Injection, Oral and Spray . The proportion of Injection in 2017 is about 68%, and the proportion of Oral in 2017 is about 32%.
The drugs for Cyanocobalamin is used to treat and prevent a lack of vitamin B12 that may be caused by any of the following: pernicious anemia (lack of a natural substance needed to absorb vitamin B12 from the intestine); certain diseases, infections, or medications that decrease the amount of vitamin B12 absorbed from food; or a vegan diet (strict vegetarian diet that does not allow any animal products, including dairy products and eggs).
Drugs for Cyanocobalamin is application in Hospital & Clinic and Pharmacy. The most of Oral is used in Pharmacy.
The report offers detailed coverage of Vitamin B12 (Cobalamin, Cyanocobalamin) industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Vitamin B12 (Cobalamin, Cyanocobalamin) by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Vitamin B12 (Cobalamin, Cyanocobalamin) market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Vitamin B12 (Cobalamin, Cyanocobalamin) market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Bristol-Myers Squibb
Sanofi-Aventis
Jamieson
Teva (Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical
At the same time, we classify Vitamin B12 (Cobalamin, Cyanocobalamin) according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Cyanocobalamin Injection
Cyanocobalamin Oral
Cyanocobalamin Spray
Market by Application
Hospitals
Clinics
Others
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Vitamin B12 (Cobalamin, Cyanocobalamin) market for the forecast period 2021 - 2025?
• What are the driving forces in the Vitamin B12 (Cobalamin, Cyanocobalamin) market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Vitamin B12 (Cobalamin, Cyanocobalamin) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?